The JCMT Gould Belt Survey: the effect of molecular contamination in SCUBA-2 observations of Orion A

Thermal emission from cold dust grains in giant molecular clouds can be used to probe the physical properties, such as density, temperature and emissivity in star-forming regions. We present the SCUBA-2 shared-risk observations at 450 $\mu$m and 850 $\mu$m of the Orion A molecular cloud complex taken at the James Clerk Maxwell Telescope (JCMT). Previous studies showed that molecular emission lines can contribute significantly to the measured fluxes in those continuum bands. We use the HARP $^{12}$CO J=3-2 integrated intensity map for Orion A in order to evaluate the molecular line contamination and its effects on the SCUBA-2 maps. With the corrected fluxes, we have obtained a new spectral index $\alpha$ map for the thermal emission of dust in the well-known integral-shaped filament. Furthermore, we compare a sample of 33 sources, selected over the Orion A molecular cloud complex for their high $^{12}$CO J=3-2 line contamination, to 27 previously identified clumps in OMC-4. This allows us to quantify the effect of line contamination on the ratio of 850 $\mu$m to 450 $\mu$m flux densities and how it modifies the deduced spectral index of emissivity $\beta$ for the dust grains. We also show that at least one Spitzer-identified protostellar core in OMC-5 has a $^{12}$CO J=3-2 contamination level of 16 %. Furthermore, we find the strongest contamination level (44 %) towards a young star with disk near OMC-2. This work is part of the JCMT Gould Belt Legacy Survey.Comment: 13 pages, 6 figures, Accepted for publication in Monthly Notices of the Royal Astronomical Society (MNRAS

The JCMT Gould Belt Survey: the effect of molecular contamination in SCUBA-2 observations of Orion A

JOURThis is the final version of the article. It was first published by Oxford Journals for the Royal Astronomical Society via http://dx.doi.org/ 10.1093/mnras/stv3009Thermal emission from cold dust grains in giant molecular clouds can be used to probe the physical properties, such as density, temperature and emissivity in star-forming regions. We present the Submillimetre Common-User Bolometer Array (SCUBA-2) shared-risk observations at 450 and 850 μm of the Orion A molecular cloud complex taken at the James Clerk Maxwell Telescope (JCMT). Previous studies showed that molecular emission lines can contribute significantly to the measured fluxes in those continuum bands. We use the Heterodyne Array Receiver Programme 12CO J = 3-2 integrated intensity map for Orion A in order to evaluate the molecular line contamination and its effects on the SCUBA-2 maps. With the corrected fluxes, we have obtained a new spectral index α map for the thermal emission of dust in the well-known integral-shaped filament. Furthermore, we compare a sample of 33 sources, selected over the Orion A molecular cloud complex for their high 12CO J = 3-2 line contamination, to 27 previously identified clumps in OMC 4. This allows us to quantify the effect of line contamination on the ratio of 850-450 μm flux densities and how it modifies the deduced spectral index of emissivity β for the dust grains. We also show that at least one Spitzer-identified protostellar core in OMC 5 has a 12CO J = 3-2 contamination level of 16 per cent. Furthermore, we find the strongest contamination level (44 per cent) towards a young star with disc near OMC 2. This work is part of the JCMT Gould Belt Legacy Survey

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Confronting or Complementing? A Case Study on NGO-State Relations from Kerala, India

Contains fulltext : 90089.pdf (publisher's version ) (Closed access)NGOs have, of late, found some of their traditional domains, such as provision of micro-credit and participatory development, coinciding with or being taken away by the state. How do they position themselves and retain relevance vis-a-vis the state in the changed scenario? Tracing the trajectory of interventions of a local NGO in Kerala, India, this article shows that NGOs exhibit ‘multiple identities’— selective collaboration, gap-filling and posing alternatives—in the process of engagement with the state. The ‘strategizing’ of such identities may hold the key to their relevance vis-a-vis the state

Tumor Necrosis Factor Gene Polymorphisms in Turkish Patients with Sarcoidosis

Background As reported recently, some gene polymorphisms are suspected to determine susceptibility to sarcoidosis and are held responsible for the extent and progression of the disease. Polymorphism at -857 locus of tumor necrosis factor (TNF)-alpha gene is considered to be a predisposition factor in sarcoidosis and held responsible for pathogenesis of the disease. We compared these polymorphisms in healthy Turkish control subjects and Turkish patients with sarcoidosis